Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours.

CONCLUSION: These findings suggest that overexpression of these new markers may be useful in identifying and targeting ovarian CSCs and CD24 may be a putative CSCs marker in ovarian cancer.
PMID: 32224528 [PubMed - as supplied by publisher]

Source: Cancer Biomarkers : Section A of Disease Markers - March 19, 2020 Category: Cancer & Oncology Authors: Nagare RP, Sneha S, Sidhanth C, Roopa S, Murhekar K, Shirley S, Swaminathan R, Sridevi V, Ganesan TS Tags: Cancer Biomark Source Type: research